| Intervention Area | Comparison Area | Effect | ||||||
---|---|---|---|---|---|---|---|---|---|
Intention to treat * | Events | PYAR | Rate | Events | PYAR | Rate | RR (95% CI) | p value | PE (95% CI) |
Malaria incidence (first or only) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Crude | 315 | 2048.3 | 0.154 | 448 | 1882.7 | 0.238 | 0.65 (0.56-0.75) | < 0.001 | 35% (25%,44%) |
adjusted ‡ |  |  |  |  |  |  | 0.75 (0.24-2.31) | 0.584 | 25% (-131%,76%) |
Malaria incidence (all episodes) | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Crude | 329 | 2105.9 | 0.156 | 507 | 1946.0 | 0.261 | 0.60 (0.52-0.69) | < 0.001 | 40% (31%,48%) |
adjusted †‡ |  |  |  |  |  |  | 0.82 (0.29-2.29) | 0.663 | 18% (-129%,71%) |
 | IPTi Intervention Area | Corresponding EPI vaccine Comparison Area | Effect | ||||||
Per protocol ** | Events | PYAR | Rate | Events | PYAR | Rate | RR (95% CI) | p value | PE (95% CI) |
Malaria incidence (all episodes) in ATAR since IPTi dose | Â | Â | Â | Â | Â | Â | Â | Â | Â |
IPTi dose 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
crude | 79 | 623.2 | 0.127 | 125 | 513.1 | 0.244 | 0.52 (0.39-0.69) | < 0.001 | 48% (31%,61%) |
adjusted †‡ |  |  |  |  |  |  | 0.68 (0.21-2.22) | 0.498 | 32% (-122%,79%) |
Malaria incidence within 28 days of IPTi dose | Â | Â | Â | Â | Â | Â | Â | Â | Â |
IPTi dose 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
crude | 7 | 95.1 | 0.070 | 13 | 81.0 | 0.160 | 0.46 (0.18-1.15) | 0.088 | 54% (-15%,82%) |
adjusted ‡ |  |  |  |  |  |  | 0.48 (0.11-2.13) | 0.341 | 52% (-113%,89%) |